摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

phosphoric acid;[(2R,3R,4S)-2,3,4,6-tetrahydroxy-5-oxohexyl] dihydrogen phosphate

中文名称
——
中文别名
——
英文名称
phosphoric acid;[(2R,3R,4S)-2,3,4,6-tetrahydroxy-5-oxohexyl] dihydrogen phosphate
英文别名
——
phosphoric acid;[(2R,3R,4S)-2,3,4,6-tetrahydroxy-5-oxohexyl] dihydrogen phosphate化学式
CAS
——
化学式
C6H16O13P2
mdl
——
分子量
358.13
InChiKey
UUYHUWHFSVRHOC-RWOHWRPJSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -4.19
  • 重原子数:
    21
  • 可旋转键数:
    7
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.83
  • 拓扑面积:
    243
  • 氢给体数:
    9
  • 氢受体数:
    13

文献信息

  • METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERS
    申请人:Agios Pharmaceuticals, Inc.
    公开号:EP3064595A1
    公开(公告)日:2016-09-07
    Methods of treating and evaluating subjects having neoactive mutants of IDH (e.g., IDH1 or IDH2).
    治疗和评估IDH(如IDH1或IDH2)新活性突变体受试者的方法。
  • CARBON-NEUTRAL AND CARBON-POSITIVE PHOTORESPIRATION BYPASS ROUTES SUPPORTING HIGHER PHOTOSYNTHETIC RATE AND YIELD
    申请人:Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
    公开号:EP3313994A1
    公开(公告)日:2018-05-02
  • PROBIOTIC COMPOSITIONS AND METHODS FOR THE TREATMENT OF OBESITY AND OBESITY-RELATED CONDITIONS
    申请人:PROTHERA, Inc.
    公开号:US20140079676A1
    公开(公告)日:2014-03-20
    The present invention provides a method and composition for ameliorating or reducing the symptoms and signs and for the treatment of obesity, diabetes, and related conditions in a mammal in need thereof, said method comprising administering effective amounts of a pharmaceutically acceptable composition comprising a mixture of probiotic microorganisms with distinct but complementary pathways of carbohydrate metabolism, for a time sufficient to ameliorate, reduce or treat at least one sign or symptom of obesity, diabetes or cardiovascular disease. Compositions having the desired properties, and methods for their use in pharmaceutical and nutritional formulations, are provided.
  • MICROORGANISM HAVING ENHANCED CELLULOSE PRODUCTIVITY, METHOD OF PRODUCING CELLULOSE BY USING THE SAME, AND METHOD OF PRODUCING THE MICROORGANISM
    申请人:Samsung Electronics Co., Ltd.
    公开号:US20190144904A1
    公开(公告)日:2019-05-16
    Provided are a microorganism having enhanced cellulose productivity, a method of producing cellulose by using the microorganism, and a method of producing the microorganism.
  • [EN] CARBON-NEUTRAL AND CARBON-POSITIVE PHOTORESPIRATION BYPASS ROUTES SUPPORTING HIGHER PHOTOSYNTHETIC RATE AND YIELD<br/>[FR] VOIES DE CONTOURNEMENT DE LA PHOTORESPIRATION NEUTRES ET POSITIVES SUR LE PLAN DU CARBONE PERMETTANT D'OBTENIR UNE VITESSE ET UN RENDEMENT SUPÉRIEURS DE LA PHOTOSYNTHÈSE
    申请人:MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WSS E V
    公开号:WO2016207219A1
    公开(公告)日:2016-12-29
    The present invention relates to an organism, a tissue, a cell or an organelle expressing enzymes which allow the conversion of 2-phosphoglycolate (2-PG; also known as glycolate 2-phosphate,) into an intermediate compound of the Calvin-Benson-Bassham Cycle (CBBC) without releasing CO2. The organism, tissue, cell or organelle of the invention may be genetically engineered, transgenic and/or transplastomic so as to express at least one enzyme which is involved in this conversion. The present invention further relates to an organism, tissue, cell or organelle which comprises/expresses at least one enzyme which is involved in this conversion. The present invention further relates to a method for producing an organism, tissue, cell or organelle of the invention. The present invention further relates to a method of enzymatically converting 2-PG into an intermediate compound of the CBBC without releasing CO2. The present invention further relates to the use of an organism, tissue, cell or organelle of the invention for enzymatically converting 2-PG into an intermediate compound of the CBBC without releasing CO2.
查看更多